Welcome to our dedicated page for COHERENT SEC filings (Ticker: COHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Coherent Corp. filings document the formal disclosures of a Pennsylvania operating company whose common stock trades on the New York Stock Exchange under COHR. Recent Form 8-K reports cover quarterly operating results, Regulation FD investor materials, executive transition matters, shareholder-vote results and capital-structure events.
The filing record also documents securities registered under Section 12(b), a completed private placement of common stock to NVIDIA, Series B convertible preferred stock and a dividend-rights waiver by its holder. These disclosures connect Coherent's photonics operations with governance, ownership, financing and reporting matters, including exhibits furnished with earnings releases and investor presentations.
Coherent Corp. director reports stock sale
A director of Coherent Corp. (COHR) reported selling 2,831 shares of Coherent common stock on 11/21/2025 at a price of $134.85 per share. After this transaction, the director beneficially owns 21,078 shares of Coherent common stock in direct ownership. The filing is a routine Form 4 disclosure of insider trading activity required by U.S. securities regulations.
BCPE Watson (DE) BML, LP, an affiliate of Bain Capital, updated its ownership report for Coherent Corp. common stock. The reporting person now beneficially owns 14,868,245 shares of common stock, representing 7.9% of the class, primarily through convertible Series B preferred stock. On November 24, 2025, it converted 20,977 shares of Series B-1 and 33,135 shares of Series B-2 preferred into 7,592,307 common shares and sold 7,500,000 common shares in a Rule 144 block trade at $143.37 per share, for total proceeds of $1,075,275,000. The holder plans to distribute 92,307 common shares to its members or partners for charitable gifts for no consideration. A new Conversion Cap Agreement limits its beneficial ownership to 9.99%, and a Waiver Agreement gives up rights to dividends on all Series B preferred stock on or after November 20, 2025.
Coherent (COHR) shareholder BCPE Watson (DE) BML, LP has filed a Form 144 to sell 7,500,000 shares of Coherent common stock through Goldman Sachs & Co. LLC on the NYSE. The shares have an stated aggregate market value of $1,075,275,000 and are part of a class with 157,153,611 shares outstanding. The stock is identified as common stock with no par value, and the approximate sale date listed is November 24, 2025.
The shares to be sold were acquired on November 25, 2025 upon conversion of Series B-1 and Series B-2 Convertible Preferred Stock, which were each settled with cash on March 31, 2021 and July 1, 2022, respectively, for a total of 2,971,280 and 4,528,720 shares. The filing also reports that BCPE Watson (DE) BML, LP sold 7,500,000 Coherent common shares on November 7, 2025 for gross proceeds of $1,075,275,000. The seller represents that it is not aware of any undisclosed material adverse information about Coherent’s current or prospective operations.
Coherent Corp. (COHR) reported an insider stock sale by a director. On 11/20/2025, the reporting person sold 2,000 shares of Coherent common stock at a price of $150 per share, as shown in Table I of the filing. The transaction is coded as an open market or similar sale and was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2024. Following this sale, the reporting person beneficially owns 20,108 shares of Coherent common stock, held directly.
Coherent Corp. insider plans a small Rule 144 stock sale. A holder has filed a notice to sell 2,831 shares of common stock of the issuer through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $381,760.35. The filing states that 157,153,611 shares of common stock were outstanding, providing context for the planned sale.
The shares to be sold were acquired on 08/28/2025 as restricted stock that vested under a registered plan from the issuer in exchange for services rendered, with payment also made on 08/28/2025. The person filing represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
Coherent Corp. announced that it has entered into a Waiver Agreement with Bain Capital, the holder of its Series B-1 and Series B-2 Convertible Preferred Stock. Under this agreement, Bain Capital irrevocably and unconditionally waives all rights to receive dividends on any shares of these Series B preferred stocks from the date of the agreement onward, as provided under the existing share terms.
The company notes that Bain Capital, which retains a substantial ownership position in Coherent despite prior sales and charitable distributions, agreed to this waiver as part of a mutually negotiated arrangement. Coherent highlights the waiver as a positive development that it believes strengthens alignment between Bain Capital and common shareholders and reflects support for the company’s strategic priorities.
COHR filed a Form 144 indicating that an affiliated seller plans to sell 2,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE around 11/20/2025, with an indicated aggregate market value of $285,880. These 2,000 shares were acquired as restricted stock units from the issuer on 08/28/2024, with payment also dated 08/28/2024.
The filing notes that 157,153,611 shares of common stock were outstanding. It also discloses prior 10b5-1 plan sales for Stephen Skaggs in the past three months: 2,000 common shares sold on 10/29/2025 for gross proceeds of $280,000 and 2,000 common shares sold on 10/24/2025 for gross proceeds of $260,000.
Coherent Corp. (COHR) reported an insider stock sale by one of its directors. On 11/14/2025, the director sold 11,570 shares of common stock in an open-market transaction coded "S" at a weighted average price of $144.875 per share.
After this sale, the director beneficially owns 12,085 shares of Coherent common stock, held directly. The price reflects multiple sale transactions within a range from $144.85 to $144.96, with the director committing to provide detailed breakdowns of shares sold at each price upon request.
Coherent Corp. held its Annual Meeting of Shareholders on November 13, 2025, with 163,694,370 votes represented, about 87.62% of votes entitled to be cast. Shareholders elected Enrico DiGirolamo, David L. Motley, Lisa Neal-Graves, Shaker Sadasivam, and Michelle Sterling as Class Two Directors to serve until the 2028 annual meeting or until successors are elected and qualified. As of the September 15, 2025 record date, 156,935,310 common shares plus Series B-1 and B-2 preferred shares were outstanding and entitled to vote on an as-converted basis. Shareholders approved on a non-binding advisory basis the 2025 executive compensation, with 147,235,758 votes for and 5,194,005 against. They also ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending June 30, 2026, with 161,561,608 votes for and 1,597,686 against.
COHR: A holder filed a Form 144 notice to sell up to 11,570 shares of common stock through Morgan Stanley Smith Barney LLC on or after 11/14/2025 on the NYSE, reflecting an aggregate market value of $1,676,203.75.
The shares were acquired via restricted stock vesting under a registered plan on multiple dates, including 8/28/2024 (6,363), 8/28/2022 (2,328), 10/07/2021 (800), 10/07/2020 (800), and 8/28/2021 (1,279), in each case for services rendered. Shares outstanding were 157,153,611; this is a baseline figure, not the amount being sold.